nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—CYP2C19—Desloratadine—allergic rhinitis	0.0462	0.0698	CbGbCtD
Regorafenib—CYP2B6—Diphenhydramine—allergic rhinitis	0.0417	0.0631	CbGbCtD
Regorafenib—CYP2C9—Desloratadine—allergic rhinitis	0.0384	0.0581	CbGbCtD
Regorafenib—ABCB1—Desloratadine—allergic rhinitis	0.0372	0.0564	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—allergic rhinitis	0.033	0.0499	CbGbCtD
Regorafenib—CYP2C8—Loratadine—allergic rhinitis	0.0316	0.0478	CbGbCtD
Regorafenib—CYP2C8—Montelukast—allergic rhinitis	0.0316	0.0478	CbGbCtD
Regorafenib—CYP2C19—Loratadine—allergic rhinitis	0.0265	0.0401	CbGbCtD
Regorafenib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0265	0.0401	CbGbCtD
Regorafenib—CYP3A4—Flunisolide—allergic rhinitis	0.0223	0.0338	CbGbCtD
Regorafenib—CYP2C9—Diphenhydramine—allergic rhinitis	0.022	0.0334	CbGbCtD
Regorafenib—CYP2C9—Montelukast—allergic rhinitis	0.022	0.0334	CbGbCtD
Regorafenib—CYP2C9—Loratadine—allergic rhinitis	0.022	0.0334	CbGbCtD
Regorafenib—ABCB1—Loratadine—allergic rhinitis	0.0214	0.0324	CbGbCtD
Regorafenib—CYP3A4—Olopatadine—allergic rhinitis	0.021	0.0317	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—allergic rhinitis	0.0205	0.0311	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—allergic rhinitis	0.0196	0.0296	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0176	0.0266	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—allergic rhinitis	0.0144	0.0218	CbGbCtD
Regorafenib—CYP3A4—Montelukast—allergic rhinitis	0.0128	0.0194	CbGbCtD
Regorafenib—CYP3A4—Loratadine—allergic rhinitis	0.0128	0.0194	CbGbCtD
Regorafenib—ABCB1—Betamethasone—allergic rhinitis	0.0127	0.0192	CbGbCtD
Regorafenib—ABCB1—Prednisolone—allergic rhinitis	0.0126	0.019	CbGbCtD
Regorafenib—ABCB1—Hydrocortisone—allergic rhinitis	0.0119	0.018	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0117	0.0177	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—allergic rhinitis	0.0109	0.0165	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—allergic rhinitis	0.00917	0.0139	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—allergic rhinitis	0.00888	0.0134	CbGbCtD
Regorafenib—RET—autonomic nervous system—allergic rhinitis	0.00804	0.067	CbGeAlD
Regorafenib—CYP2C9—Dexamethasone—allergic rhinitis	0.00763	0.0115	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—allergic rhinitis	0.00762	0.0115	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—allergic rhinitis	0.00752	0.0114	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—allergic rhinitis	0.0074	0.0112	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00713	0.0108	CbGbCtD
Regorafenib—CYP3A4—Dexamethasone—allergic rhinitis	0.00443	0.00671	CbGbCtD
Regorafenib—DDR2—respiratory system—allergic rhinitis	0.00385	0.0321	CbGeAlD
Regorafenib—FGFR2—exocrine gland—allergic rhinitis	0.00377	0.0315	CbGeAlD
Regorafenib—DDR2—eye—allergic rhinitis	0.00351	0.0293	CbGeAlD
Regorafenib—DDR2—skin of body—allergic rhinitis	0.00306	0.0255	CbGeAlD
Regorafenib—KIT—exocrine gland—allergic rhinitis	0.00262	0.0218	CbGeAlD
Regorafenib—EPHX2—eye—allergic rhinitis	0.00237	0.0198	CbGeAlD
Regorafenib—FLT4—respiratory system—allergic rhinitis	0.00234	0.0195	CbGeAlD
Regorafenib—FLT4—eye—allergic rhinitis	0.00214	0.0178	CbGeAlD
Regorafenib—DDR2—lung—allergic rhinitis	0.00204	0.017	CbGeAlD
Regorafenib—FGFR2—respiratory system—allergic rhinitis	0.00196	0.0164	CbGeAlD
Regorafenib—FLT4—epithelium—allergic rhinitis	0.00196	0.0163	CbGeAlD
Regorafenib—EPHA2—respiratory system—allergic rhinitis	0.00193	0.0161	CbGeAlD
Regorafenib—FGFR1—bronchus—allergic rhinitis	0.0019	0.0159	CbGeAlD
Regorafenib—TEK—respiratory system—allergic rhinitis	0.00188	0.0157	CbGeAlD
Regorafenib—FLT1—respiratory system—allergic rhinitis	0.00182	0.0152	CbGeAlD
Regorafenib—RAF1—respiratory system—allergic rhinitis	0.00181	0.0151	CbGeAlD
Regorafenib—FGFR2—eye—allergic rhinitis	0.0018	0.015	CbGeAlD
Regorafenib—RET—epithelium—allergic rhinitis	0.00173	0.0144	CbGeAlD
Regorafenib—PDGFRA—respiratory system—allergic rhinitis	0.00171	0.0142	CbGeAlD
Regorafenib—FLT1—eye—allergic rhinitis	0.00166	0.0139	CbGeAlD
Regorafenib—RAF1—eye—allergic rhinitis	0.00165	0.0138	CbGeAlD
Regorafenib—FGFR2—epithelium—allergic rhinitis	0.00164	0.0137	CbGeAlD
Regorafenib—EPHA2—epithelium—allergic rhinitis	0.00161	0.0135	CbGeAlD
Regorafenib—EPHA2—bronchus—allergic rhinitis	0.00159	0.0132	CbGeAlD
Regorafenib—TEK—epithelium—allergic rhinitis	0.00157	0.0131	CbGeAlD
Regorafenib—FGFR2—skin of body—allergic rhinitis	0.00156	0.013	CbGeAlD
Regorafenib—TEK—bronchus—allergic rhinitis	0.00155	0.0129	CbGeAlD
Regorafenib—KDR—respiratory system—allergic rhinitis	0.00154	0.0128	CbGeAlD
Regorafenib—FLT1—epithelium—allergic rhinitis	0.00152	0.0127	CbGeAlD
Regorafenib—RAF1—epithelium—allergic rhinitis	0.00151	0.0126	CbGeAlD
Regorafenib—FLT1—bronchus—allergic rhinitis	0.0015	0.0125	CbGeAlD
Regorafenib—RAF1—bronchus—allergic rhinitis	0.00149	0.0124	CbGeAlD
Regorafenib—BRAF—lung—allergic rhinitis	0.00144	0.012	CbGeAlD
Regorafenib—RAF1—skin of body—allergic rhinitis	0.00144	0.012	CbGeAlD
Regorafenib—EPHA2—trachea—allergic rhinitis	0.00143	0.0119	CbGeAlD
Regorafenib—KDR—eye—allergic rhinitis	0.00141	0.0117	CbGeAlD
Regorafenib—EPHX2—lung—allergic rhinitis	0.00138	0.0115	CbGeAlD
Regorafenib—KIT—respiratory system—allergic rhinitis	0.00136	0.0114	CbGeAlD
Regorafenib—FLT1—trachea—allergic rhinitis	0.00135	0.0112	CbGeAlD
Regorafenib—RAF1—trachea—allergic rhinitis	0.00134	0.0112	CbGeAlD
Regorafenib—PDGFRB—respiratory system—allergic rhinitis	0.00133	0.0111	CbGeAlD
Regorafenib—KDR—epithelium—allergic rhinitis	0.00129	0.0107	CbGeAlD
Regorafenib—KDR—bronchus—allergic rhinitis	0.00127	0.0106	CbGeAlD
Regorafenib—PDGFRA—trachea—allergic rhinitis	0.00126	0.0105	CbGeAlD
Regorafenib—FLT4—lung—allergic rhinitis	0.00124	0.0104	CbGeAlD
Regorafenib—FGFR1—lung—allergic rhinitis	0.00123	0.0102	CbGeAlD
Regorafenib—PDGFRB—eye—allergic rhinitis	0.00122	0.0101	CbGeAlD
Regorafenib—ABL1—respiratory system—allergic rhinitis	0.00119	0.0099	CbGeAlD
Regorafenib—KIT—epithelium—allergic rhinitis	0.00114	0.0095	CbGeAlD
Regorafenib—KDR—trachea—allergic rhinitis	0.00114	0.00948	CbGeAlD
Regorafenib—KIT—bronchus—allergic rhinitis	0.00112	0.00936	CbGeAlD
Regorafenib—PDGFRB—epithelium—allergic rhinitis	0.00111	0.00928	CbGeAlD
Regorafenib—PDGFRB—bronchus—allergic rhinitis	0.0011	0.00914	CbGeAlD
Regorafenib—ABL1—eye—allergic rhinitis	0.00109	0.00905	CbGeAlD
Regorafenib—KIT—skin of body—allergic rhinitis	0.00108	0.00904	CbGeAlD
Regorafenib—PDGFRB—skin of body—allergic rhinitis	0.00106	0.00883	CbGeAlD
Regorafenib—FGFR2—lung—allergic rhinitis	0.00104	0.0087	CbGeAlD
Regorafenib—EPHA2—lung—allergic rhinitis	0.00103	0.00855	CbGeAlD
Regorafenib—KIT—trachea—allergic rhinitis	0.00101	0.00841	CbGeAlD
Regorafenib—TEK—lung—allergic rhinitis	0.001	0.00834	CbGeAlD
Regorafenib—PDGFRB—trachea—allergic rhinitis	0.000985	0.00821	CbGeAlD
Regorafenib—ABL1—bronchus—allergic rhinitis	0.000978	0.00815	CbGeAlD
Regorafenib—FLT1—lung—allergic rhinitis	0.000967	0.00806	CbGeAlD
Regorafenib—RAF1—lung—allergic rhinitis	0.000961	0.00801	CbGeAlD
Regorafenib—ABL1—skin of body—allergic rhinitis	0.000944	0.00787	CbGeAlD
Regorafenib—PDGFRA—lung—allergic rhinitis	0.000906	0.00755	CbGeAlD
Regorafenib—ABL1—trachea—allergic rhinitis	0.000878	0.00732	CbGeAlD
Regorafenib—KDR—lung—allergic rhinitis	0.000818	0.00681	CbGeAlD
Regorafenib—KIT—lung—allergic rhinitis	0.000724	0.00604	CbGeAlD
Regorafenib—PDGFRB—lung—allergic rhinitis	0.000708	0.0059	CbGeAlD
Regorafenib—CYP2B6—respiratory system—allergic rhinitis	0.000691	0.00576	CbGeAlD
Regorafenib—ABL1—lung—allergic rhinitis	0.000631	0.00526	CbGeAlD
Regorafenib—Diarrhoea—Desloratadine—allergic rhinitis	0.000584	0.00397	CcSEcCtD
Regorafenib—Hypertension—Loratadine—allergic rhinitis	0.000582	0.00395	CcSEcCtD
Regorafenib—Erythema multiforme—Montelukast—allergic rhinitis	0.000578	0.00392	CcSEcCtD
Regorafenib—Abdominal pain—Olopatadine—allergic rhinitis	0.000577	0.00392	CcSEcCtD
Regorafenib—Body temperature increased—Olopatadine—allergic rhinitis	0.000577	0.00392	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.00057	0.00387	CcSEcCtD
Regorafenib—CYP2B6—bronchus—allergic rhinitis	0.000569	0.00474	CbGeAlD
Regorafenib—Cardiac disorder—Montelukast—allergic rhinitis	0.000567	0.00385	CcSEcCtD
Regorafenib—Dry mouth—Loratadine—allergic rhinitis	0.000562	0.00381	CcSEcCtD
Regorafenib—Vomiting—Cyproheptadine—allergic rhinitis	0.000559	0.00379	CcSEcCtD
Regorafenib—Rash—Cyproheptadine—allergic rhinitis	0.000554	0.00376	CcSEcCtD
Regorafenib—Dermatitis—Cyproheptadine—allergic rhinitis	0.000554	0.00376	CcSEcCtD
Regorafenib—Mediastinal disorder—Montelukast—allergic rhinitis	0.000551	0.00374	CcSEcCtD
Regorafenib—Headache—Cyproheptadine—allergic rhinitis	0.00055	0.00374	CcSEcCtD
Regorafenib—CYP2B6—skin of body—allergic rhinitis	0.000549	0.00458	CbGeAlD
Regorafenib—Hypertension—Cetirizine—allergic rhinitis	0.000548	0.00372	CcSEcCtD
Regorafenib—Vomiting—Desloratadine—allergic rhinitis	0.000543	0.00369	CcSEcCtD
Regorafenib—Nervous system disorder—Loratadine—allergic rhinitis	0.00054	0.00366	CcSEcCtD
Regorafenib—Hypertension—Flunisolide—allergic rhinitis	0.000539	0.00366	CcSEcCtD
Regorafenib—Rash—Desloratadine—allergic rhinitis	0.000539	0.00366	CcSEcCtD
Regorafenib—Gastroenteritis—Hydrocortisone—allergic rhinitis	0.000538	0.00365	CcSEcCtD
Regorafenib—Dermatitis—Desloratadine—allergic rhinitis	0.000538	0.00365	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.000537	0.00364	CcSEcCtD
Regorafenib—Headache—Desloratadine—allergic rhinitis	0.000535	0.00363	CcSEcCtD
Regorafenib—Skin disorder—Loratadine—allergic rhinitis	0.000535	0.00363	CcSEcCtD
Regorafenib—Dry mouth—Cetirizine—allergic rhinitis	0.000528	0.00359	CcSEcCtD
Regorafenib—Asthenia—Olopatadine—allergic rhinitis	0.000524	0.00356	CcSEcCtD
Regorafenib—Nausea—Cyproheptadine—allergic rhinitis	0.000522	0.00354	CcSEcCtD
Regorafenib—Infection—Cetirizine—allergic rhinitis	0.000514	0.00349	CcSEcCtD
Regorafenib—Asthenia—Diphenhydramine—allergic rhinitis	0.000513	0.00348	CcSEcCtD
Regorafenib—Asthenia—Dimenhydrinate—allergic rhinitis	0.000513	0.00348	CcSEcCtD
Regorafenib—Nervous system disorder—Cetirizine—allergic rhinitis	0.000508	0.00345	CcSEcCtD
Regorafenib—Nausea—Desloratadine—allergic rhinitis	0.000507	0.00344	CcSEcCtD
Regorafenib—Thrombocytopenia—Cetirizine—allergic rhinitis	0.000507	0.00344	CcSEcCtD
Regorafenib—Infection—Flunisolide—allergic rhinitis	0.000506	0.00343	CcSEcCtD
Regorafenib—Skin disorder—Cetirizine—allergic rhinitis	0.000503	0.00341	CcSEcCtD
Regorafenib—Diarrhoea—Olopatadine—allergic rhinitis	0.0005	0.00339	CcSEcCtD
Regorafenib—Tremor—Montelukast—allergic rhinitis	0.000499	0.00338	CcSEcCtD
Regorafenib—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000489	0.00332	CcSEcCtD
Regorafenib—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000489	0.00332	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000475	0.00323	CcSEcCtD
Regorafenib—Fatigue—Loratadine—allergic rhinitis	0.000475	0.00322	CcSEcCtD
Regorafenib—Pain—Loratadine—allergic rhinitis	0.000471	0.00319	CcSEcCtD
Regorafenib—Vomiting—Olopatadine—allergic rhinitis	0.000464	0.00315	CcSEcCtD
Regorafenib—Rash—Olopatadine—allergic rhinitis	0.00046	0.00313	CcSEcCtD
Regorafenib—Dermatitis—Olopatadine—allergic rhinitis	0.00046	0.00312	CcSEcCtD
Regorafenib—Headache—Olopatadine—allergic rhinitis	0.000457	0.00311	CcSEcCtD
Regorafenib—Vomiting—Dimenhydrinate—allergic rhinitis	0.000454	0.00308	CcSEcCtD
Regorafenib—Vomiting—Diphenhydramine—allergic rhinitis	0.000454	0.00308	CcSEcCtD
Regorafenib—Rash—Dimenhydrinate—allergic rhinitis	0.000451	0.00306	CcSEcCtD
Regorafenib—Rash—Diphenhydramine—allergic rhinitis	0.000451	0.00306	CcSEcCtD
Regorafenib—Decreased appetite—Cetirizine—allergic rhinitis	0.00045	0.00306	CcSEcCtD
Regorafenib—Dermatitis—Diphenhydramine—allergic rhinitis	0.00045	0.00306	CcSEcCtD
Regorafenib—Dermatitis—Dimenhydrinate—allergic rhinitis	0.00045	0.00306	CcSEcCtD
Regorafenib—Gastrointestinal pain—Loratadine—allergic rhinitis	0.00045	0.00305	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.00045	0.00305	CcSEcCtD
Regorafenib—Dry skin—Prednisolone—allergic rhinitis	0.000448	0.00304	CcSEcCtD
Regorafenib—Headache—Dimenhydrinate—allergic rhinitis	0.000448	0.00304	CcSEcCtD
Regorafenib—Headache—Diphenhydramine—allergic rhinitis	0.000448	0.00304	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000447	0.00303	CcSEcCtD
Regorafenib—Fatigue—Cetirizine—allergic rhinitis	0.000446	0.00303	CcSEcCtD
Regorafenib—Pain—Cetirizine—allergic rhinitis	0.000443	0.00301	CcSEcCtD
Regorafenib—Decreased appetite—Flunisolide—allergic rhinitis	0.000443	0.003	CcSEcCtD
Regorafenib—Fatigue—Flunisolide—allergic rhinitis	0.000439	0.00298	CcSEcCtD
Regorafenib—Dry skin—Hydrocortisone—allergic rhinitis	0.000437	0.00297	CcSEcCtD
Regorafenib—Pain—Flunisolide—allergic rhinitis	0.000435	0.00296	CcSEcCtD
Regorafenib—Body temperature increased—Loratadine—allergic rhinitis	0.000435	0.00295	CcSEcCtD
Regorafenib—Abdominal pain—Loratadine—allergic rhinitis	0.000435	0.00295	CcSEcCtD
Regorafenib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000434	0.00295	CcSEcCtD
Regorafenib—Nausea—Olopatadine—allergic rhinitis	0.000434	0.00294	CcSEcCtD
Regorafenib—Infection—Montelukast—allergic rhinitis	0.000431	0.00293	CcSEcCtD
Regorafenib—Nervous system disorder—Montelukast—allergic rhinitis	0.000426	0.00289	CcSEcCtD
Regorafenib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000425	0.00289	CcSEcCtD
Regorafenib—Nausea—Diphenhydramine—allergic rhinitis	0.000424	0.00288	CcSEcCtD
Regorafenib—Nausea—Dimenhydrinate—allergic rhinitis	0.000424	0.00288	CcSEcCtD
Regorafenib—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000423	0.00287	CcSEcCtD
Regorafenib—Skin disorder—Montelukast—allergic rhinitis	0.000422	0.00286	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000421	0.00286	CcSEcCtD
Regorafenib—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000416	0.00283	CcSEcCtD
Regorafenib—Abdominal pain—Cetirizine—allergic rhinitis	0.000409	0.00278	CcSEcCtD
Regorafenib—Body temperature increased—Cetirizine—allergic rhinitis	0.000409	0.00278	CcSEcCtD
Regorafenib—Abdominal pain—Flunisolide—allergic rhinitis	0.000403	0.00273	CcSEcCtD
Regorafenib—Body temperature increased—Flunisolide—allergic rhinitis	0.000403	0.00273	CcSEcCtD
Regorafenib—ABCG2—lung—allergic rhinitis	0.000398	0.00332	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000395	0.00268	CcSEcCtD
Regorafenib—Asthenia—Loratadine—allergic rhinitis	0.000395	0.00268	CcSEcCtD
Regorafenib—Diarrhoea—Loratadine—allergic rhinitis	0.000377	0.00256	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000375	0.00254	CcSEcCtD
Regorafenib—Fatigue—Montelukast—allergic rhinitis	0.000374	0.00254	CcSEcCtD
Regorafenib—Dry skin—Dexamethasone—allergic rhinitis	0.000374	0.00254	CcSEcCtD
Regorafenib—Dry skin—Betamethasone—allergic rhinitis	0.000374	0.00254	CcSEcCtD
Regorafenib—Weight decreased—Hydrocortisone—allergic rhinitis	0.000373	0.00253	CcSEcCtD
Regorafenib—Asthenia—Cetirizine—allergic rhinitis	0.000372	0.00252	CcSEcCtD
Regorafenib—Pain—Montelukast—allergic rhinitis	0.000371	0.00252	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisolone—allergic rhinitis	0.000371	0.00252	CcSEcCtD
Regorafenib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000371	0.00252	CcSEcCtD
Regorafenib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000371	0.00252	CcSEcCtD
Regorafenib—ABCB1—respiratory system—allergic rhinitis	0.000369	0.00308	CbGeAlD
Regorafenib—Myocardial infarction—Prednisolone—allergic rhinitis	0.000369	0.00251	CcSEcCtD
Regorafenib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000368	0.0025	CcSEcCtD
Regorafenib—Infestation—Hydrocortisone—allergic rhinitis	0.000368	0.0025	CcSEcCtD
Regorafenib—CYP2B6—lung—allergic rhinitis	0.000367	0.00306	CbGeAlD
Regorafenib—Asthenia—Flunisolide—allergic rhinitis	0.000365	0.00248	CcSEcCtD
Regorafenib—Acute coronary syndrome—Hydrocortisone—allergic rhinitis	0.000362	0.00246	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrocortisone—allergic rhinitis	0.00036	0.00245	CcSEcCtD
Regorafenib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000355	0.00241	CcSEcCtD
Regorafenib—Diarrhoea—Cetirizine—allergic rhinitis	0.000354	0.00241	CcSEcCtD
Regorafenib—Vomiting—Loratadine—allergic rhinitis	0.00035	0.00238	CcSEcCtD
Regorafenib—Diarrhoea—Flunisolide—allergic rhinitis	0.000348	0.00236	CcSEcCtD
Regorafenib—Rash—Loratadine—allergic rhinitis	0.000347	0.00236	CcSEcCtD
Regorafenib—Dermatitis—Loratadine—allergic rhinitis	0.000347	0.00235	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000345	0.00234	CcSEcCtD
Regorafenib—Infestation—Methylprednisolone—allergic rhinitis	0.000345	0.00234	CcSEcCtD
Regorafenib—Headache—Loratadine—allergic rhinitis	0.000345	0.00234	CcSEcCtD
Regorafenib—Body temperature increased—Montelukast—allergic rhinitis	0.000343	0.00233	CcSEcCtD
Regorafenib—Abdominal pain—Montelukast—allergic rhinitis	0.000343	0.00233	CcSEcCtD
Regorafenib—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.000341	0.00232	CcSEcCtD
Regorafenib—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.000341	0.00231	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—allergic rhinitis	0.00034	0.00231	CcSEcCtD
Regorafenib—Myocardial infarction—Triamcinolone—allergic rhinitis	0.000339	0.0023	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—allergic rhinitis	0.000339	0.0023	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—allergic rhinitis	0.000338	0.00229	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000332	0.00225	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.00033	0.00224	CcSEcCtD
Regorafenib—Vomiting—Cetirizine—allergic rhinitis	0.000329	0.00224	CcSEcCtD
Regorafenib—Nausea—Loratadine—allergic rhinitis	0.000327	0.00222	CcSEcCtD
Regorafenib—Rash—Cetirizine—allergic rhinitis	0.000327	0.00222	CcSEcCtD
Regorafenib—Dermatitis—Cetirizine—allergic rhinitis	0.000326	0.00221	CcSEcCtD
Regorafenib—Headache—Cetirizine—allergic rhinitis	0.000324	0.0022	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000324	0.0022	CcSEcCtD
Regorafenib—Vomiting—Flunisolide—allergic rhinitis	0.000324	0.0022	CcSEcCtD
Regorafenib—Rash—Flunisolide—allergic rhinitis	0.000321	0.00218	CcSEcCtD
Regorafenib—Dermatitis—Flunisolide—allergic rhinitis	0.000321	0.00218	CcSEcCtD
Regorafenib—Headache—Flunisolide—allergic rhinitis	0.000319	0.00217	CcSEcCtD
Regorafenib—Weight decreased—Dexamethasone—allergic rhinitis	0.000319	0.00216	CcSEcCtD
Regorafenib—Weight decreased—Betamethasone—allergic rhinitis	0.000319	0.00216	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000312	0.00212	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000312	0.00212	CcSEcCtD
Regorafenib—Asthenia—Montelukast—allergic rhinitis	0.000312	0.00211	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000311	0.00211	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.00031	0.00211	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.00031	0.0021	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.00031	0.0021	CcSEcCtD
Regorafenib—ABCB1—epithelium—allergic rhinitis	0.000309	0.00257	CbGeAlD
Regorafenib—Myocardial infarction—Betamethasone—allergic rhinitis	0.000308	0.00209	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000308	0.00209	CcSEcCtD
Regorafenib—Nausea—Cetirizine—allergic rhinitis	0.000308	0.00209	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000305	0.00207	CcSEcCtD
Regorafenib—Nausea—Flunisolide—allergic rhinitis	0.000302	0.00205	CcSEcCtD
Regorafenib—Diarrhoea—Montelukast—allergic rhinitis	0.000297	0.00202	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000288	0.00195	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000287	0.00195	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—allergic rhinitis	0.000283	0.00192	CcSEcCtD
Regorafenib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000283	0.00192	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000282	0.00191	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—allergic rhinitis	0.000282	0.00191	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000281	0.00191	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000279	0.0019	CcSEcCtD
Regorafenib—Vomiting—Montelukast—allergic rhinitis	0.000276	0.00187	CcSEcCtD
Regorafenib—Rash—Montelukast—allergic rhinitis	0.000274	0.00186	CcSEcCtD
Regorafenib—Dermatitis—Montelukast—allergic rhinitis	0.000274	0.00186	CcSEcCtD
Regorafenib—ABCB1—trachea—allergic rhinitis	0.000273	0.00228	CbGeAlD
Regorafenib—Headache—Montelukast—allergic rhinitis	0.000272	0.00185	CcSEcCtD
Regorafenib—Malnutrition—Methylprednisolone—allergic rhinitis	0.00027	0.00183	CcSEcCtD
Regorafenib—Nausea—Montelukast—allergic rhinitis	0.000258	0.00175	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—allergic rhinitis	0.000256	0.00174	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—allergic rhinitis	0.000256	0.00174	CcSEcCtD
Regorafenib—Hypertension—Prednisolone—allergic rhinitis	0.000254	0.00172	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—allergic rhinitis	0.000249	0.00169	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—allergic rhinitis	0.000249	0.00169	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—allergic rhinitis	0.000248	0.00168	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000243	0.00165	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—allergic rhinitis	0.000234	0.00159	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—allergic rhinitis	0.000233	0.00158	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—allergic rhinitis	0.000233	0.00158	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.00023	0.00156	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000228	0.00155	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000228	0.00155	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—allergic rhinitis	0.000225	0.00153	CcSEcCtD
Regorafenib—Infection—Triamcinolone—allergic rhinitis	0.000219	0.00149	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—allergic rhinitis	0.000219	0.00149	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000216	0.00147	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000214	0.00145	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—allergic rhinitis	0.000212	0.00144	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—allergic rhinitis	0.000212	0.00144	CcSEcCtD
Regorafenib—Pain—Prednisolone—allergic rhinitis	0.000205	0.00139	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000204	0.00138	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000202	0.00137	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—allergic rhinitis	0.000202	0.00137	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—allergic rhinitis	0.000201	0.00136	CcSEcCtD
Regorafenib—Infection—Dexamethasone—allergic rhinitis	0.000199	0.00135	CcSEcCtD
Regorafenib—Infection—Betamethasone—allergic rhinitis	0.000199	0.00135	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000196	0.00133	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000196	0.00133	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000196	0.00133	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000196	0.00133	CcSEcCtD
Regorafenib—ABCB1—lung—allergic rhinitis	0.000196	0.00163	CbGeAlD
Regorafenib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000192	0.0013	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—allergic rhinitis	0.00019	0.00129	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—allergic rhinitis	0.00019	0.00129	CcSEcCtD
Regorafenib—Pain—Triamcinolone—allergic rhinitis	0.000189	0.00128	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000185	0.00126	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000185	0.00126	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.00018	0.00122	CcSEcCtD
Regorafenib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000175	0.00118	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000174	0.00118	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000174	0.00118	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—allergic rhinitis	0.000174	0.00118	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000173	0.00117	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000173	0.00117	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—allergic rhinitis	0.000173	0.00117	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—allergic rhinitis	0.000173	0.00117	CcSEcCtD
Regorafenib—Pain—Dexamethasone—allergic rhinitis	0.000171	0.00116	CcSEcCtD
Regorafenib—Pain—Betamethasone—allergic rhinitis	0.000171	0.00116	CcSEcCtD
Regorafenib—Asthenia—Hydrocortisone—allergic rhinitis	0.000168	0.00114	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000164	0.00111	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000164	0.00111	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.00016	0.00109	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—allergic rhinitis	0.000158	0.00108	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000158	0.00108	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—allergic rhinitis	0.000158	0.00108	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—allergic rhinitis	0.000158	0.00108	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—allergic rhinitis	0.000158	0.00108	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—allergic rhinitis	0.000158	0.00107	CcSEcCtD
Regorafenib—Rash—Prednisolone—allergic rhinitis	0.000151	0.00103	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—allergic rhinitis	0.000151	0.00103	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000151	0.00102	CcSEcCtD
Regorafenib—Headache—Prednisolone—allergic rhinitis	0.00015	0.00102	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—allergic rhinitis	0.000149	0.00101	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—allergic rhinitis	0.000148	0.001	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—allergic rhinitis	0.000148	0.001	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—allergic rhinitis	0.000147	0.000997	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—allergic rhinitis	0.000144	0.000976	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—allergic rhinitis	0.000144	0.000976	CcSEcCtD
Regorafenib—Nausea—Prednisolone—allergic rhinitis	0.000143	0.000968	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—allergic rhinitis	0.00014	0.000953	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—allergic rhinitis	0.00014	0.000951	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—allergic rhinitis	0.000139	0.000946	CcSEcCtD
Regorafenib—Rash—Triamcinolone—allergic rhinitis	0.000139	0.000945	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—allergic rhinitis	0.000139	0.000944	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—allergic rhinitis	0.000139	0.000943	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000139	0.000942	CcSEcCtD
Regorafenib—Headache—Triamcinolone—allergic rhinitis	0.000138	0.000939	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—allergic rhinitis	0.000138	0.000937	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—allergic rhinitis	0.000137	0.000931	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000137	0.000931	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—allergic rhinitis	0.000131	0.00089	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—allergic rhinitis	0.000131	0.000888	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—allergic rhinitis	0.000127	0.000865	CcSEcCtD
Regorafenib—Vomiting—Betamethasone—allergic rhinitis	0.000127	0.000865	CcSEcCtD
Regorafenib—Rash—Dexamethasone—allergic rhinitis	0.000126	0.000858	CcSEcCtD
Regorafenib—Rash—Betamethasone—allergic rhinitis	0.000126	0.000858	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—allergic rhinitis	0.000126	0.000857	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—allergic rhinitis	0.000126	0.000857	CcSEcCtD
Regorafenib—Headache—Betamethasone—allergic rhinitis	0.000126	0.000852	CcSEcCtD
Regorafenib—Headache—Dexamethasone—allergic rhinitis	0.000126	0.000852	CcSEcCtD
Regorafenib—Nausea—Betamethasone—allergic rhinitis	0.000119	0.000808	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—allergic rhinitis	0.000119	0.000808	CcSEcCtD
Regorafenib—BRAF—Signaling Pathways—PTGDR2—allergic rhinitis	7.53e-05	0.00105	CbGpPWpGaD
Regorafenib—PDGFRA—B Cell Activation—NFKB1—allergic rhinitis	7.52e-05	0.00105	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-G—allergic rhinitis	7.47e-05	0.00104	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.34e-05	0.00102	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	7.32e-05	0.00102	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TAC1—allergic rhinitis	7.32e-05	0.00102	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	7.14e-05	0.000995	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCL11—allergic rhinitis	7.09e-05	0.000989	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	7.07e-05	0.000986	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	7.06e-05	0.000984	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—SMAD3—allergic rhinitis	7.05e-05	0.000983	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTGDR2—allergic rhinitis	6.98e-05	0.000973	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CYSLTR1—allergic rhinitis	6.94e-05	0.000967	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.93e-05	0.000966	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.92e-05	0.000965	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—NFKB1—allergic rhinitis	6.91e-05	0.000964	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—NFKB1—allergic rhinitis	6.91e-05	0.000964	CbGpPWpGaD
Regorafenib—RAF1—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	6.87e-05	0.000958	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-G—allergic rhinitis	6.86e-05	0.000956	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTGDR2—allergic rhinitis	6.86e-05	0.000956	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL5—allergic rhinitis	6.8e-05	0.000949	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	6.8e-05	0.000948	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—NFKB1—allergic rhinitis	6.77e-05	0.000944	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-G—allergic rhinitis	6.74e-05	0.000939	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	6.71e-05	0.000936	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCL11—allergic rhinitis	6.7e-05	0.000934	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—TGFB1—allergic rhinitis	6.7e-05	0.000934	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCL11—allergic rhinitis	6.69e-05	0.000932	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—TGFB1—allergic rhinitis	6.64e-05	0.000926	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.58e-05	0.000917	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.56e-05	0.000915	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	6.52e-05	0.00091	CbGpPWpGaD
Regorafenib—UGT1A1—NRF2 pathway—TGFB1—allergic rhinitis	6.52e-05	0.000909	CbGpPWpGaD
Regorafenib—UGT1A9—NRF2 pathway—TGFB1—allergic rhinitis	6.52e-05	0.000909	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTGDR2—allergic rhinitis	6.51e-05	0.000907	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTGDR2—allergic rhinitis	6.49e-05	0.000905	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—NFKB1—allergic rhinitis	6.48e-05	0.000904	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—NFKB1—allergic rhinitis	6.42e-05	0.000896	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—SMAD3—allergic rhinitis	6.42e-05	0.000895	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-G—allergic rhinitis	6.39e-05	0.000891	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	6.38e-05	0.00089	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-G—allergic rhinitis	6.38e-05	0.000889	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	6.37e-05	0.000888	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TGFB1—allergic rhinitis	6.36e-05	0.000886	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—SMAD3—allergic rhinitis	6.17e-05	0.000861	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	6.14e-05	0.000856	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL5—allergic rhinitis	6.02e-05	0.000839	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CYSLTR1—allergic rhinitis	5.97e-05	0.000832	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—NFKB1—allergic rhinitis	5.95e-05	0.00083	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CYSLTR1—allergic rhinitis	5.91e-05	0.000824	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-DQB1—allergic rhinitis	5.91e-05	0.000824	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTGDR2—allergic rhinitis	5.85e-05	0.000815	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—NFKB1—allergic rhinitis	5.85e-05	0.000815	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCL11—allergic rhinitis	5.76e-05	0.000803	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TGFB1—allergic rhinitis	5.76e-05	0.000803	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-G—allergic rhinitis	5.74e-05	0.000801	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCL11—allergic rhinitis	5.71e-05	0.000796	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	5.67e-05	0.00079	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—SMAD3—allergic rhinitis	5.65e-05	0.000787	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-G—allergic rhinitis	5.6e-05	0.00078	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	5.59e-05	0.000779	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—NFKB1—allergic rhinitis	5.55e-05	0.000774	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—NFKB1—allergic rhinitis	5.53e-05	0.000772	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL5—allergic rhinitis	5.53e-05	0.000771	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CYSLTR1—allergic rhinitis	5.48e-05	0.000764	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL5—allergic rhinitis	5.43e-05	0.000757	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CYSLTR1—allergic rhinitis	5.38e-05	0.00075	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL11—allergic rhinitis	5.29e-05	0.000738	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	5.27e-05	0.000734	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTGDR2—allergic rhinitis	5.21e-05	0.000727	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL11—allergic rhinitis	5.2e-05	0.000724	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TAC1—allergic rhinitis	5.15e-05	0.000718	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL5—allergic rhinitis	5.15e-05	0.000718	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—ICAM1—allergic rhinitis	5.15e-05	0.000718	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL5—allergic rhinitis	5.14e-05	0.000716	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-G—allergic rhinitis	5.12e-05	0.000714	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	5.11e-05	0.000713	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CYSLTR1—allergic rhinitis	5.11e-05	0.000712	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CYSLTR1—allergic rhinitis	5.09e-05	0.00071	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—ICAM1—allergic rhinitis	5.06e-05	0.000705	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—NFKB1—allergic rhinitis	4.99e-05	0.000695	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL11—allergic rhinitis	4.93e-05	0.000688	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL11—allergic rhinitis	4.92e-05	0.000686	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	4.89e-05	0.000681	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—NFKB1—allergic rhinitis	4.87e-05	0.000679	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TAC1—allergic rhinitis	4.87e-05	0.000679	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TAC1—allergic rhinitis	4.86e-05	0.000677	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—ICAM1—allergic rhinitis	4.8e-05	0.000669	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL5—allergic rhinitis	4.79e-05	0.000668	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SMAD3—allergic rhinitis	4.79e-05	0.000668	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—ICAM1—allergic rhinitis	4.79e-05	0.000667	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-DQB1—allergic rhinitis	4.66e-05	0.00065	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL5—allergic rhinitis	4.63e-05	0.000645	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CYSLTR1—allergic rhinitis	4.59e-05	0.00064	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	4.55e-05	0.000634	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL5—allergic rhinitis	4.53e-05	0.000631	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	4.52e-05	0.00063	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL5—allergic rhinitis	4.52e-05	0.00063	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL5—allergic rhinitis	4.51e-05	0.000629	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—NFKB1—allergic rhinitis	4.44e-05	0.00062	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL11—allergic rhinitis	4.43e-05	0.000618	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—ICAM1—allergic rhinitis	4.31e-05	0.000601	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—CD4—allergic rhinitis	4.29e-05	0.000598	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-DQB1—allergic rhinitis	4.28e-05	0.000597	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—SMAD3—allergic rhinitis	4.21e-05	0.000587	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-DQB1—allergic rhinitis	4.2e-05	0.000586	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—NFKB1—allergic rhinitis	4.19e-05	0.000584	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TAC1—allergic rhinitis	4.19e-05	0.000584	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TAC1—allergic rhinitis	4.15e-05	0.000578	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL5—allergic rhinitis	4.13e-05	0.000575	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CYSLTR1—allergic rhinitis	4.09e-05	0.00057	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TGFB1—allergic rhinitis	4.06e-05	0.000566	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-DQB1—allergic rhinitis	3.99e-05	0.000556	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-DQB1—allergic rhinitis	3.98e-05	0.000555	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL11—allergic rhinitis	3.95e-05	0.000551	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CD4—allergic rhinitis	3.94e-05	0.000549	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL5—allergic rhinitis	3.89e-05	0.000543	CbGpPWpGaD
Regorafenib—BRAF—Disease—SMAD3—allergic rhinitis	3.88e-05	0.00054	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CD4—allergic rhinitis	3.87e-05	0.00054	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL5—allergic rhinitis	3.86e-05	0.000538	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TAC1—allergic rhinitis	3.84e-05	0.000536	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—ICAM1—allergic rhinitis	3.84e-05	0.000536	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CD4—allergic rhinitis	3.78e-05	0.000528	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TAC1—allergic rhinitis	3.78e-05	0.000526	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD4—allergic rhinitis	3.72e-05	0.000518	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—NFKB1—allergic rhinitis	3.7e-05	0.000516	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CD4—allergic rhinitis	3.67e-05	0.000512	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CD4—allergic rhinitis	3.66e-05	0.000511	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SMAD3—allergic rhinitis	3.59e-05	0.000501	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-DQB1—allergic rhinitis	3.58e-05	0.0005	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—NFKB1—allergic rhinitis	3.58e-05	0.0005	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TAC1—allergic rhinitis	3.58e-05	0.0005	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TAC1—allergic rhinitis	3.57e-05	0.000498	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL5—allergic rhinitis	3.57e-05	0.000498	CbGpPWpGaD
Regorafenib—KIT—Disease—SMAD3—allergic rhinitis	3.53e-05	0.000492	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD4—allergic rhinitis	3.53e-05	0.000492	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD4—allergic rhinitis	3.52e-05	0.000491	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL5—allergic rhinitis	3.51e-05	0.000489	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	3.49e-05	0.000487	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TGFB1—allergic rhinitis	3.49e-05	0.000486	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—ICAM1—allergic rhinitis	3.4e-05	0.000474	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—NFKB1—allergic rhinitis	3.4e-05	0.000473	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SMAD3—allergic rhinitis	3.37e-05	0.00047	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SMAD3—allergic rhinitis	3.35e-05	0.000467	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SMAD3—allergic rhinitis	3.34e-05	0.000466	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—NFKB1—allergic rhinitis	3.34e-05	0.000465	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL5—allergic rhinitis	3.33e-05	0.000464	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL5—allergic rhinitis	3.32e-05	0.000463	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CD4—allergic rhinitis	3.3e-05	0.00046	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NFKB1—allergic rhinitis	3.26e-05	0.000455	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—NFKB1—allergic rhinitis	3.26e-05	0.000455	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TAC1—allergic rhinitis	3.22e-05	0.000449	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CD4—allergic rhinitis	3.22e-05	0.000448	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—NFKB1—allergic rhinitis	3.2e-05	0.000446	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-DQB1—allergic rhinitis	3.2e-05	0.000445	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SMAD3—allergic rhinitis	3.19e-05	0.000444	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD4—allergic rhinitis	3.17e-05	0.000442	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—NFKB1—allergic rhinitis	3.17e-05	0.000441	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—NFKB1—allergic rhinitis	3.16e-05	0.00044	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	3.14e-05	0.000437	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ICAM1—allergic rhinitis	3.12e-05	0.000435	CbGpPWpGaD
Regorafenib—KIT—Immune System—ICAM1—allergic rhinitis	3.07e-05	0.000428	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—NFKB1—allergic rhinitis	3.04e-05	0.000424	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—NFKB1—allergic rhinitis	3.03e-05	0.000423	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SMAD3—allergic rhinitis	3.01e-05	0.000419	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL5—allergic rhinitis	2.99e-05	0.000417	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TGFB1—allergic rhinitis	2.99e-05	0.000416	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CD4—allergic rhinitis	2.94e-05	0.00041	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ICAM1—allergic rhinitis	2.91e-05	0.000406	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—ICAM1—allergic rhinitis	2.9e-05	0.000405	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.89e-05	0.000404	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—NFKB1—allergic rhinitis	2.87e-05	0.0004	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAC1—allergic rhinitis	2.87e-05	0.0004	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—NFKB1—allergic rhinitis	2.84e-05	0.000396	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD4—allergic rhinitis	2.83e-05	0.000394	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	2.77e-05	0.000386	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SMAD3—allergic rhinitis	2.74e-05	0.000382	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—NFKB1—allergic rhinitis	2.73e-05	0.000381	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TGFB1—allergic rhinitis	2.72e-05	0.000379	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SMAD3—allergic rhinitis	2.71e-05	0.000378	CbGpPWpGaD
Regorafenib—RAF1—Disease—SMAD3—allergic rhinitis	2.68e-05	0.000374	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL5—allergic rhinitis	2.67e-05	0.000372	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ICAM1—allergic rhinitis	2.62e-05	0.000365	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	2.61e-05	0.000364	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TGFB1—allergic rhinitis	2.56e-05	0.000358	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ICAM1—allergic rhinitis	2.55e-05	0.000355	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—NFKB1—allergic rhinitis	2.53e-05	0.000353	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SMAD3—allergic rhinitis	2.52e-05	0.000351	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD4—allergic rhinitis	2.5e-05	0.000349	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SMAD3—allergic rhinitis	2.47e-05	0.000344	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NFKB1—allergic rhinitis	2.43e-05	0.000339	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—NFKB1—allergic rhinitis	2.43e-05	0.000339	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.41e-05	0.000336	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TGFB1—allergic rhinitis	2.39e-05	0.000333	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TGFB1—allergic rhinitis	2.35e-05	0.000327	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SMAD3—allergic rhinitis	2.34e-05	0.000327	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SMAD3—allergic rhinitis	2.34e-05	0.000326	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ICAM1—allergic rhinitis	2.33e-05	0.000325	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD4—allergic rhinitis	2.3e-05	0.00032	CbGpPWpGaD
Regorafenib—BRAF—Disease—CD4—allergic rhinitis	2.29e-05	0.000319	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD4—allergic rhinitis	2.25e-05	0.000314	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NFKB1—allergic rhinitis	2.15e-05	0.0003	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—allergic rhinitis	2.14e-05	0.000298	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—allergic rhinitis	2.13e-05	0.000298	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—allergic rhinitis	2.12e-05	0.000295	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SMAD3—allergic rhinitis	2.11e-05	0.000294	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—allergic rhinitis	2.08e-05	0.00029	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TGFB1—allergic rhinitis	2.03e-05	0.000283	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NFKB1—allergic rhinitis	1.98e-05	0.000276	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—allergic rhinitis	1.98e-05	0.000275	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—allergic rhinitis	1.97e-05	0.000275	CbGpPWpGaD
Regorafenib—KIT—Immune System—NFKB1—allergic rhinitis	1.94e-05	0.000271	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—allergic rhinitis	1.92e-05	0.000268	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SMAD3—allergic rhinitis	1.88e-05	0.000262	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—allergic rhinitis	1.87e-05	0.000261	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NFKB1—allergic rhinitis	1.84e-05	0.000257	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NFKB1—allergic rhinitis	1.84e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—allergic rhinitis	1.78e-05	0.000247	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKB1—allergic rhinitis	1.71e-05	0.000239	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—allergic rhinitis	1.71e-05	0.000239	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKB1—allergic rhinitis	1.66e-05	0.000231	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—allergic rhinitis	1.64e-05	0.000229	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKB1—allergic rhinitis	1.62e-05	0.000226	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKB1—allergic rhinitis	1.61e-05	0.000225	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—allergic rhinitis	1.58e-05	0.000221	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—allergic rhinitis	1.52e-05	0.000212	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—allergic rhinitis	1.49e-05	0.000208	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKB1—allergic rhinitis	1.48e-05	0.000206	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—allergic rhinitis	1.43e-05	0.000199	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—allergic rhinitis	1.42e-05	0.000198	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—allergic rhinitis	1.41e-05	0.000197	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKB1—allergic rhinitis	1.39e-05	0.000194	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKB1—allergic rhinitis	1.38e-05	0.000192	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—allergic rhinitis	1.35e-05	0.000188	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKB1—allergic rhinitis	1.28e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—allergic rhinitis	1.27e-05	0.000178	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKB1—allergic rhinitis	1.26e-05	0.000175	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKB1—allergic rhinitis	1.19e-05	0.000166	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKB1—allergic rhinitis	1.19e-05	0.000166	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—allergic rhinitis	1.16e-05	0.000162	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—allergic rhinitis	1.15e-05	0.00016	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—allergic rhinitis	1.14e-05	0.000158	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKB1—allergic rhinitis	1.07e-05	0.000149	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—allergic rhinitis	1.07e-05	0.000148	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—allergic rhinitis	1.05e-05	0.000146	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—allergic rhinitis	9.93e-06	0.000138	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—allergic rhinitis	9.9e-06	0.000138	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKB1—allergic rhinitis	9.55e-06	0.000133	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—allergic rhinitis	8.92e-06	0.000124	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—allergic rhinitis	7.95e-06	0.000111	CbGpPWpGaD
